Compare Tata India Pharma & Healthcare Fund vs SBI Healthcare Opportunities Fund
Risk | Very High | Very High |
Rating | 3.0 | 5.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 2.1 | 1.93 |
NAV | ₹29.99 | ₹422.25 |
Fund Started | 04 Dec 2015 | 04 Jun 1999 |
Fund Size | ₹1338.85 Cr | ₹4130.76 Cr |
Exit Load | Exit load of 0.25% if redeemed within 30 days. | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.1
1.93
NAV
₹29.99
₹422.25
Fund Started
04 Dec 2015
04 Jun 1999
Fund Size
₹1338.85 Cr
₹4130.76 Cr
Exit Load
Exit load of 0.25% if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
1 Year | -1.27% | -1.09% |
3 Year | 22.13% | 23.81% |
5 Year | 15.40% | 16.93% |
1 Year
-1.27%
-1.09%
3 Year
22.13%
23.81%
5 Year
15.40%
16.93%
Equity | 95.00% | 95.82% |
Cash | 5.00% | 4.11% |
Equity
95.00%
95.82%
Cash
5.00%
4.11%
Top 10 Holdings |
|
|
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 7.75% |
Max Healthcare Institute Ltd. | 5.65% |
Healthcare Global Enterprises Ltd. | 5.13% |
Abbott India Ltd. | 5.04% |
Apollo Hospitals Enterprise Ltd. | 4.85% |
Ipca Laboratories Ltd. | 3.99% |
Cipla Ltd. | 3.96% |
Rainbow Children's Medicare Ltd. | 3.78% |
Lupin Ltd. | 3.57% |
Ajanta Pharma Ltd. | 3.45% |
Sun Pharmaceutical Industries Ltd. | 11.97% |
Divi's Laboratories Ltd. | 6.90% |
Max Healthcare Institute Ltd. | 5.63% |
Cipla Ltd. | 4.45% |
Lupin Ltd. | 4.23% |
Lonza Group Ag | 4.01% |
Acutaas Chemicals Ltd. | 4.00% |
Torrent Pharmaceuticals Ltd. | 3.60% |
Laurus Labs Ltd. | 3.50% |
Fortis Healthcare Ltd. | 3.34% |
Name | Meeta Shetty | Tanmaya Desai |
Start Date | 11 Nov 2024 | 17 May 2024 |
Name
Meeta Shetty
Tanmaya Desai
Start Date
11 Nov 2024
17 May 2024
Description | The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 04 Dec 2015 | 04 Jun 1999 |
Description
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
04 Dec 2015
04 Jun 1999